All the top Biotech & Pharma news in one daily newsletter.

Want to understand how these updates are formatted? Check-out the FAQ.

Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

THE GOOD
Approvals & Labels

BeOne Medicines' BRUKINSA tablet formulation receives EC approval for all B-cell cancer indications, reducing pill burden
Small molecule, cancer, kinase inhibitor, B-cell malignancies, BTK inhibitor, oral formulation - Read more

THE GOOD
Business Development & Partnerships

IMBiologics, GeneQuantum partner to develop antibody-drug conjugates combining ePENDY platform with linker-payload technology
Co-development, antibody-drug conjugates, oncology, drug discovery, technology platform - Read more

AAHI partners with Quratis as preferred manufacturer for vaccine development, strengthening global access to tuberculosis, malaria, and HIV vaccines
Manufacturing agreement, vaccine, infectious disease, global, manufacturing - Read more

OpenAI, Retro Biosciences complete joint AI protein model project with promising lab results for drug development
Research collaboration, AI/ML, drug discovery, protein engineering, longevity, R&D - Read more

PRESENTED BY YOU?
Get the attention of 2000+ Biotech & Pharma Professionals 🤩

Do you offer a biotech/pharma-focused product or service?

Or looking to get investor/analyst interest on your budding start-up?

Considering sponsoring TLDR Biotech to get in-front of an engaged audience of biotech & pharma-focused professionals.

Just reply to this email* or message me on LinkedIn to learn more.

*If you’re reading this on the web version, email [email protected]

✅ More Good News ✅

THE GOOD
Fundraises

Lighthouse Pharmaceuticals receives $49.2M NIA grant for Alzheimer's trial targeting bacteria-related disease
Alzheimer disease, infectious disease, small molecule, clinical-stage, neuroinflammation - Read more

Molecular You raises $5M Series A, AI-powered molecular testing for preventive health
Preventive health, biomarker discovery, AI-driven, diagnostic platform, personalized medicine - Read more

LB Pharmaceuticals files for $100M IPO, developing therapies for neuropsychiatric diseases
Neuropsychiatric, small molecule, schizophrenia, clinical-stage - Read more

Invivyd raises $57.5M public offering, advancing respiratory virus treatments and Long COVID research
Infectious disease, antibody, clinical-stage, platform technology, respiratory - Read more

THE GOOD
Investments

Varro Life Sciences invests $42.5M in new St. Louis lab, creating 33 jobs for biosensor development
Biosensor device, infectious disease, operational, investment - Read more

THE GOOD
Regulatory

Biohaven shares rise after FDA removes advisory committee requirement for troriluzole's SCA approval path
Small molecule, neurological, rare disease, regulatory, strategic - Read more

FDA announces daily publication of adverse event reports to increase transparency
Pharmacovigilance, regulatory, operational, transparency - Read more

THE GOOD
Strategic Plans

Bavarian Nordic CEO advocates for $3 billion buyout to fund portfolio growth amid rising sales
Vaccines, infectious disease, strategic, financial, potential acquisition - Read more

THE BAD
Layoffs

Arena BioWorks cuts 30% of staff, shifts focus from cell and gene therapy to small molecules and biologics
Small molecule, biologics, strategic, cost reduction, operational - Read more

CDC cuts 600 jobs including violence prevention staff after partial court protection
Public health, government workforce, operational, financial, strategic - Read more

THE BAD
Market Reports

Obesity drug market falters as Novo, Lilly, and Viking face disappointing clinical results
GLP-1 receptor agonist, metabolic disease, competitive landscape, financial impact, strategic - Read more [Paywall]

THE BAD
Regulatory

Vanda Pharmaceuticals challenges FDA's approval of Hetlioz generics after court win for sleep disorder drug
Melatonin receptor agonist, sleep disorder, regulatory, competitive - Read more

THE UGLY
Politics & Policy

UK drug pricing talks collapse as pharma industry rejects government's £1 billion ($1.34B) offer to lower rebate rates
Pharmaceutical policy, healthcare economics, strategic, financial, regulatory - Read more

Supreme Court allows $783M NIH grant cuts related to DEI under Trump administration
Research funding, regulatory, operational, financial, competitive - Read more

THE UGLY
Regulatory

Novo-acquired Catalent plant faces FDA scrutiny for contamination and pest issues affecting multiple drugmakers
Manufacturing, ophthalmology, neurology, operational, regulatory, quality control - Read more

B. Braun Medical recalls two injections nationwide due to particulate matter contamination risk
Injectable medicine, safety recall, operational, regulatory, quality control - Read more

You’re all caught up on the latest Pharma & Biotech News!

TLDR Biotech wants to hear from you! 📣

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

If you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

And lastly - connect with me on LinkedIn!

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here